Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system. Maccura Biotechnology Co.Ltd was founded in 1994 and is headquartered in Chengdu, China.
Metrics to compare | 300463 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300463PeersSector | |
---|---|---|---|---|
P/E Ratio | −181.5x | 59.8x | −0.5x | |
PEG Ratio | 1.64 | 0.15 | 0.00 | |
Price/Book | 1.2x | 4.6x | 2.6x | |
Price / LTM Sales | 3.2x | 8.1x | 3.3x | |
Upside (Analyst Target) | 20.8% | 1.0% | 38.7% | |
Fair Value Upside | Unlock | 4.0% | 5.2% | Unlock |